Franklin Friedman
Director/Board Member at DECIPHERA PHARMACEUTICALS, INC.
Net worth: 157 300 $ as of 2024-03-30
Profile
Franklin S.
Friedman is currently the President & Chief Executive Officer at IPFS Corp.
He is also a Director at Deciphera Pharmaceuticals LLC and an Independent Director at Deciphera Pharmaceuticals, Inc. Previously, he worked at Deloitte LLP (New York) and Deloitte Touche Tohmatsu Ltd.
for 40 years, where he served as the Global Chief Operating Officer from 2016 to 2019.
He received his undergraduate degree from the University of Kansas in 1979.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-15 | 10,000 ( 0.01% ) | 157 300 $ | 2024-03-30 |
Franklin Friedman active positions
| Companies | Position | Start |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Director/Board Member | 2019-10-31 |
IPFS Corp.
 IPFS Corp. Insurance Brokers/ServicesFinance IPFS Corp. engages in the provision of insurance brokerage services. The company was founded by Tom Charbonneau in 1977 and is headquartered in Kansas City, MO. | Chief Executive Officer | 2018-12-31 |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Director/Board Member | 2019-10-31 |
Former positions of Franklin Friedman
| Companies | Position | End |
|---|---|---|
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Chief Executive Officer | 2014-12-31 |
Deloitte Touche Tohmatsu Ltd.
 Deloitte Touche Tohmatsu Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu Ltd. provides auditing, financial advisory, tax, and consulting services. Its serves technology, consumer business, energy and resources, financial services, life sciences and health care, manufacturing, public sector, real estate, technology, media, and telecommunications industries. The company was founded in 1880 and is headquartered in New York, NY. | Chief Executive Officer | 2014-12-31 |
Training of Franklin Friedman
| University of Kansas | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
IPFS Corp.
IPFS Corp. Insurance Brokers/ServicesFinance IPFS Corp. engages in the provision of insurance brokerage services. The company was founded by Tom Charbonneau in 1977 and is headquartered in Kansas City, MO. | Finance |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Commercial Services |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
Deloitte Touche Tohmatsu Ltd.
Deloitte Touche Tohmatsu Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu Ltd. provides auditing, financial advisory, tax, and consulting services. Its serves technology, consumer business, energy and resources, financial services, life sciences and health care, manufacturing, public sector, real estate, technology, media, and telecommunications industries. The company was founded in 1880 and is headquartered in New York, NY. | Commercial Services |
| Deciphera Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Franklin Friedman
